| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::CHANGES IN SUBSTANTIAL SHAREHOLDER'S INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016 | 1 | SGX Company Announcements | ||
| Mo | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::CHANGES IN DIRECTOR'S INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016 | 1 | SGX Company Announcements | ||
| Mo | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::DEALINGS OUTSIDE CLOSED PERIOD | 1 | SGX Company Announcements | ||
| TOP GLOVE Aktie jetzt für 0€ handeln | |||||
| Do | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::CHANGES IN SUBSTANTIAL SHAREHOLDER'S INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016 | 1 | SGX Company Announcements | ||
| Do | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::CHANGES IN DIRECTOR'S INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016 | 2 | SGX Company Announcements | ||
| Do | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::DEALINGS OUTSIDE CLOSED PERIOD | 1 | SGX Company Announcements | ||
| 30.01. | TOP GLOVE CORPORATION BHD: EMPLOYEE STOCK OPTION/SHARE SCHEME::OFFER OF OPTIONS UNDER THE EMPLOYEES SHARE OPTION SCHEME OF THE COMPANY ("ESOS) | 2 | SGX Company Announcements | ||
| 30.01. | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::CHANGES IN SUBSTANTIAL SHAREHOLDER'S INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016 | 1 | SGX Company Announcements | ||
| 30.01. | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::CHANGES IN DIRECTOR'S INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016 | - | SGX Company Announcements | ||
| 30.01. | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::DEALINGS OUTSIDE CLOSED PERIOD | - | SGX Company Announcements | ||
| 26.01. | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::CHANGES IN SUBSTANTIAL SHAREHOLDER'S INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016 | 1 | SGX Company Announcements | ||
| 26.01. | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::CHANGES IN DIRECTOR'S INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016 | 1 | SGX Company Announcements | ||
| 26.01. | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::DEALINGS OUTSIDE CLOSED PERIOD | 1 | SGX Company Announcements | ||
| 20.01. | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::CHANGES IN SUBSTANTIAL SHAREHOLDER'S INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016 | 1 | SGX Company Announcements | ||
| 20.01. | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::CHANGES IN DIRECTOR'S INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016 | 1 | SGX Company Announcements | ||
| 20.01. | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::DEALINGS OUTSIDE CLOSED PERIOD | 1 | SGX Company Announcements | ||
| 12.01. | TOP GLOVE CORPORATION BHD: GENERAL ANNOUNCEMENT::ISSUANCE OF SHARES PURSUANT TO EXERCISE OF WARRANTS | 1 | SGX Company Announcements | ||
| 08.01. | TOP GLOVE CORPORATION BHD: REQUEST FOR LIFTING OF TRADING HALT::REQUEST FOR LIFTING OF TRADING HALT | 1 | SGX Company Announcements | ||
| 08.01. | TOP GLOVE CORPORATION BHD: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 08.01. | TOP GLOVE CORPORATION BHD: REQUEST FOR TRADING HALT::REQUEST FOR TRADING HALT | 2 | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,500 | +2,92 % | Eckert&Ziegler: Radiopharma als Treiber | Im vierten Quartal verbessert Eckert&Ziegler den Umsatz um 9 Prozent auf 87,9 Millionen Euro. Dabei haben Währungsschwankungen einen höheren Umsatz verhindert. Das bereinigte EBIT legt um 41 Prozent... ► Artikel lesen | |
| DRAEGERWERK | 87,20 | 0,00 % | DAX wartet auf Fed - Airbus, Bayer, Drägerwerk, Infineon, SUSS Microtec, Wacker Chemie im ... | Am deutschen Aktienmarkt herrscht zu Handelsbeginn wenig Bewegung - die Anleger warten gespannt auf die nächste Notenbankentscheidung in den USA heute Abend. Am Vortag scheiterte der DAX zudem an der... ► Artikel lesen | |
| TELADOC HEALTH | 4,246 | +1,48 % | Teladoc Health, Inc.: Teladoc Health to Announce Fourth Quarter 2025 Financial Results | ||
| GERATHERM MEDICAL | 2,670 | -3,61 % | GERATHERM MEDICAL AG - Schwäche im aktuellen Marktumfeld | ||
| MOLINA HEALTHCARE | 107,45 | +0,23 % | Healthcare-Wette von Burry: Molina Healthcare stürzt brutal ab: Was bedeutet der Crash für Anleger? | © Foto: DallE - OpenAISchock-Meldung: Molina Healthcare stürzt um 33 Prozent nachbörslich ab - Analysten warnen vor tieferem Absturz! Was ist da los?Molina Healthcare hat eine schwache Prognose für... ► Artikel lesen | |
| AMBU | 11,590 | +0,09 % | Ambu A/S: Interim Report For Q1 2025/26 | 4.2.2026 07:04:05 CET | Ambu A/S |
Interim report (Q1 and Q3)
Ambu had a solid start to the 2025/26 financial year, reflected by continued strong growth momentum. Endoscopy Solutions grew by 14.4%... ► Artikel lesen | |
| FISHER & PAYKEL HEALTHCARE | 20,000 | +1,52 % | Dividendenbekanntmachungen (03.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGEAS SA/NV BE0974264930 - 1,5 EUR ALIMENTATION COUCHE-TARD INC CA01626P1484 0,215 CAD 0,1323 EUR AMKOR TECHNOLOGY INC US0316521006 0... ► Artikel lesen | |
| HEARTFLOW | 29,240 | +5,41 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 29,210 | +1,64 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BETA BIONICS | 13,870 | +6,04 % | UBS initiates coverage on Beta Bionics stock with Buy rating | ||
| GENEDX | 91,28 | +8,29 % | Forecasting The Future: 4 Analyst Projections For GeneDx Holdings | ||
| ALIGNMENT HEALTHCARE | 20,790 | -4,41 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| SIEMENS HEALTHINEERS | 41,300 | +1,23 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Analyst David Adlington glich seine Schätzungen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,740 | +0,15 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| PROGYNY | 21,650 | -1,37 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen |